Akers Biosciences Cm (AKER) 3.04 $AKER Akers Biosciences

New Post Public Reply Private Reply Replies (0) Message Board

Jul 31, 2016 at 11:23 PM

Akers Biosciences Cm (AKER) 3.04 $AKER

Akers Biosciences to Present at LD Micro Invitational Conference
Marketwire Canada - Fri Jun 03, 8:52AM CDT
THOROFARE, NJ--(Marketwired - Jun 3, 2016) - Akers Biosciences, Inc. (NASDAQ: AKER) (AIM: AKR.L) (the "Company"

, a developer of rapid health information technologies, announces that Co-founder and Chief Scientific Director, Raymond F. Akers, Jr. PhD, will present to investors attending the upcoming LD Micro Invitational Conference in Los Angeles, CA. on Tuesday June 7, 2016. Dr. Akers intends to provide an update on the Company's business including the increasing traction in the US and China of the Company's flagship rapid test for Heparin-induced thrombocytopenia.
AKER: 3.04 (+0.23)

Akers (AKER) Reports Q1 Earnings; Product Revenue Up 79.3%
Aparajita Dutta - Zacks Investment Research - Thu May 12, 7:46AM CDT
Akers' (AKER) first-quarter product revenue increased 79.3% from the year-ago quarter to $738,023
AKER: 3.04 (+0.23)

Akers Biosciences Reports Earnings for Q1 2016
Marketwire Canada - Thu May 12, 6:00AM CDT
PIFA Heparin/PF4 Rapid Tests Sales Up 88%; Total Revenues up 45%
AKER: 3.04 (+0.23), AKR: 37.66 (+0.52)

Akers Biosciences Announces Conference Call to Discuss Q1 2016 Earnings
Marketwired - Tue May 10, 6:00AM CDT
THOROFARE, NJ--(Marketwired - May 10, 2016) - Akers Biosciences, Inc. (NASDAQ: AKER) (AIM: AKR.L), ("Akers Bio" or the "Company"

, a developer of rapid health information technologies, will hold a conference call on Thursday, May 12, 2016 at 09:00 a.m. Eastern Time to discuss its earnings for the first quarter ended March 31, 2016, which will be published earlier that day. Management will be available during a question-and-answer session.
AKER: 3.04 (+0.23)

Akers Biosciences (AKER) Q1 Earnings: What's in Store?
Zacks Equity Research - Zacks Investment Research - Mon May 09, 7:52AM CDT
Akers Biosciences Inc (AKER) is expected to report first-quarter 2016 results on May 12.
CAPR: 3.70 (-0.03), STAA: 6.84 (+0.08), AKER: 3.04 (+0.23), VBLT: 4.02 (unch)

Akers Biosciences to Present at 'Pioneers 2016' Investor Conference
Marketwire Canada - Wed May 04, 1:00PM CDT
THOROFARE, NJ--(Marketwired - May 4, 2016) - Akers Biosciences, Inc. (NASDAQ: AKER) (AIM: AKR), (the "Company"

, a developer of rapid health information technologies, is presenting at Joseph Gunnar & Co., LLC's 'Pioneers 2016' conference in New York on May 5, 2016.
AKER: 3.04 (+0.23), AKR: 37.66 (+0.52)

Akers Board Rearrangement
Marketwired - Fri Apr 29, 6:01AM CDT
Akers Biosciences, Inc. (NASDAQ: AKER) (AIM: AKR.L), ("Akers Bio" or the "Company"

, a developer of rapid health information technologies, announces changes to the roles of certain board members, which take effect immediately and are designed to improve the effectiveness of the Board of Directors.
AKER: 3.04 (+0.23)

Akers' Loss Widens in 2015, Revenues Deteriorate Y/Y
Zacks Equity Research - Zacks Investment Research - Wed Mar 30, 9:46AM CDT
Akers Biosciences Inc. (AKER) reported loss of $1.81 per share in full-year 2015, much wider than 66 cents recorded in 2014.
AMZN: 758.81 (+6.20), BAX: 48.02 (-0.20), AKER: 3.04 (+0.23), HRC: 53.43 (+0.84)

Akers Biosciences Reports Earnings for Fiscal Year 2015
Marketwired - Wed Mar 30, 6:00AM CDT
Akers Biosciences, Inc. (NASDAQ: AKER) (AIM: AKR.L) ("Akers Bio" or the "Company"

, a developer of rapid health information technologies, reports its financial results for the fiscal year ended December 31, 2015.
AKER: 3.04 (+0.23)

What Awaits Akers Biosciences (AKER) in Q4 Earnings?
Zacks Equity Research - Zacks Investment Research - Mon Mar 28, 8:10AM CDT
Akers Biosciences Inc (AKER) is expected to report fourth-quarter 2015 earnings results on Mar 30.
AMZN: 758.81 (+6.20), AXDX: 19.65 (-0.44), AKER: 3.04 (+0.23)

Akers Biosciences' Protein Preparation Gets Patent Cover
Zacks Equity Research - Zacks Investment Research - Thu Mar 24, 9:10AM CDT
Akers Biosciences Inc. (AKER) recently won a patent from the United States Patent and Trademark Office (USPTO) for its proprietary protein preparation.
BAX: 48.02 (-0.20), LMAT: 17.20 (+0.61), AKER: 3.04 (+0.23), HRC: 53.43 (+0.84)

Akers Biosciences Allowed US Patent for Heparin/PF4 Antibody Detection
Marketwired - Wed Mar 23, 6:00AM CDT
Akers Biosciences, Inc. (NASDAQ: AKER) (AIM: AKR.L), ("Akers Bio" or the "Company"

, a developer of rapid health information technologies, announces that the United States Patent and Trademark Office has allowed a patent covering Akers Bio's proprietary methods for detecting heparin/platelet factor 4 antibodies (the "Patent"

.
AKER: 3.04 (+0.23)

Akers Biosciences Announces Conference Call to Discuss Its 2015 Earnings
Marketwired - Wed Mar 16, 6:00AM CDT
Akers Biosciences, Inc. (NASDAQ: AKER) (AIM: AKR.L) ("Akers Bio" or the "Company"

, a developer of health information technologies, will hold a conference call on Wednesday, March 30, 2016 at 09:00 a.m. Eastern Time to discuss its earnings, which will be published earlier that day, for the fiscal year ended December 31, 2015.
AKER: 3.04 (+0.23)

Akers Biosciences to Present at Disruptive Growth & Healthcare Conference
GlobeNewswire - Mon Feb 08, 11:18AM CST
Akers Biosciences, Inc. (NASDAQ:AKER) (AIM:AKR.L), ("Akers Bio" or the "Company"

, a developer of cutting edge technologies that deliver rapid health information, is presenting at Source Capital's 2016 Disruptive Growth & Healthcare conference in New York on February 10, 2016.
AKER: 3.04 (+0.23)

Akers Biosciences JV Facility Now Operational in China
Zacks Equity Research - Zacks Investment Research - Thu Dec 03, 11:50AM CST
Akers Biosciences (AKER) recently announced that its Chinese joint venture's 10000 square foot production facility is now fully operational.
ICUI: 116.76 (+0.71), AMZN: 758.81 (+6.20), NXTM: 22.11 (-0.15), AKER: 3.04 (+0.23)

Akers Biosciences Updates on Joint Venture in China
GlobeNewswire - Tue Dec 01, 6:00AM CST
Akers Biosciences, Inc. (NASDAQ:AKER) (AIM:AKR.L), ("Akers Bio" or the "Company"

, a developer and supplier of screening and testing technologies designed to deliver rapid health information to consumers and healthcare providers, announces an update on the progress of its 19.9%-owned Chinese joint venture company, Hainan Savy Akers Biosciences, Ltd ("Savy Akers" or the "Joint Venture"

. Savy Akers was established in October 2014 to commercialize a number of Akers Bio's rapid diagnostic screening and testing products in China (excluding PIFA Heparin/PF4 Rapid Assay products for which Chinese distribution is handled by NovoTek).
AKER: 3.04 (+0.23)

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

OmniActive's Fenavari: A New Era in Women's Health

Pioneering Women's Health with Fenavari You ever wonder why some health products get all the hype? Here's one for the book: OmniActive Health Technologies launching Fenavari, their top-tier contender in the women's health market. Now, we're not talking your run-of-the-mill supplement here. We're stepping onto a new playing field, especially with Dr. Taz Bhatia stepping...

Celebree Gains Franchise Momentum: A New Frontier

The Climb: Celebree Schools on the Rise Here's a nugget in the franchise world that's causing a stir: Celebree School is making moves up the Franchise Times Top 400. When we're talking about a hop, skip, and jump through 84 spots since 2023, you can't help but notice. It's the third year in a row they're climbing this ladder, and it's making ripples. Franchise Expansion...

Trial for Former OB/GYN Arthur Park Begins in Bakersfield

A Somber Day for Justice in Bakersfield There’s a buzz in the air, thick with anticipation and grief, as a trial seven years in the making kicks off in Bakersfield. It’s a significant affair, marking a turning point in a saga that’s shadowed the region with untold grief and unresolved accountability. We’re talking about the trial of Arthur Park, a former OB/GYN,...

Montessori and Tech: A New Era of Integration

Reimagining Montessori with Technology Let's take a stroll down the road less traveled—the intersection of Montessori education and tech. For over a century, Montessori schools have valued individual child development, autonomy, and a purpose-driven environment. But let's face it, their technology hasn't always had the same handcrafted finesse. That's where illumine...

New American Funding Expands in Carolinas with Mullinix Move

The Gathering of Mortgage Titans You don't just waltz into the mortgage world with a $2 billion track record and expect folks not to notice. Will Mullinix, a name that's become synonymous in the Carolinas with mortgage mastery, has decided to bring his influential Mullinix Mortgage Group under the banner of New American Funding. Talk about a power play. This bold strategy...

Simple Home Upgrades That Boost Value Fast

Transform Your Home's Curb Appeal Without Breaking The Bank Every homeowner knows that feeling when you look at your house one day and think, "This could use a little something." Say you're strolling through a neighborhood in Fulton, N.Y., and notice a gem. It's not a brand new build, but it gleams with character. You bet it's had a few smart touches that could apply...

Partner Valuation Advisors Bolsters Team with Eichman

Eichman Joins Partner Valuation Advisors as MD Turns out the buzz in real estate appraisal isn’t just about property values these days; it's about who's valuing them. Just ask Partner Valuation Advisors, who are realigning their chess pieces by bringing seasoned pro Justin Eichman, MAI, on board as Managing Director. Talk about playing your cards right. A Heavyweight in...

Skiptown Expands in Georgia Amid Growing Demand

With the pet care industry barking up a storm lately, Skiptown is ramping up efforts to expand its presence in Georgia. The tech-enabled dog care franchise already has a paw print in Atlanta, but it's sniffing out new opportunities across the state. Now they're on the hunt for franchise owners who can bring this modern approach to more communities. Why Georgia? The Growth...

Veterans Transitioning to Real Estate with Scholarships

Tapping Military Skills for Civilian Gain Finding a new career after military service is a mountain of a task, but veterans now have a golden ticket into the real estate appraisal world. The Appraisal Institute's Next Mission Scholarship is throwing veterans a $1,000 life preserver to dive into a field where their military-honed skills already shine. The Power of a...

Dr. Anderson’s Journey: Leadership with Faith and Service

A Life Shaped by Service Dr. Howard Anderson isn't just another name in a glossy award roster—he's a powerhouse of leadership, a chaplain of compassion, and a soldier in spirit. Honored as a Pinnacle Professional Member of The Inner Circle of Excellence, his recognition feels less like an accolade and more like a testament to a life committed to serving others. The...